to date , 924 patients with pelvic endometriosis have been treated in our department with conventional endocrine therapies , 40 patients were treated with buserelin ( d-ser ( bu ) 6 luteinizing hormone-releasing hormone monopeptide-ethylamide ) , 900 micrograms/day intranasally , and 50 patients with goserelin depot , a gnrh analog of d-ser ( bu ) 6- azegly10-gnrh , with depot applications ( 3.6 mg per 4 weeks ) .
C0120107
goserelin
C0023610
gnrh